Aldamaria PULITI

Prof. Aldamaria PULITI

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1998 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VPVeronique Pingault
Veronique Pingault
NBNadege Bondurand
Nadege Bondurand
KKKirsten Kuhlbrodt
Kirsten Kuhlbrodt
DGDerk E. Goerich
Derk E. Goerich
MPMarie-Odette Préhu
Marie-Odette Préhu
MGMichel Goossens
Michel Goossens

28 April 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
BHBeate Herbarth
Beate Herbarth
VPVeronique Pingault
Veronique Pingault
NBNadege Bondurand
Nadege Bondurand
KKKirsten Kuhlbrodt
Kirsten Kuhlbrodt
IHIrm Hermans-Borgmeyer
Irm Hermans-Borgmeyer
MWMichael Wegner
Michael Wegner
The spontaneous mouse mutant Dominant megacolon ( Dom ) is a valuable model for the study of human congenital megacolon (Hirschsprung disease). Here we report that the defect in the Dom mouse is caused by mutation of the gene encoding the Sry-related transcription factor Sox10. This assignment is based on ( i ) colocalization of the Sox10 gene with the Dom mutation on chromosome 15; ( ii ) altered Sox10 expression in the gut and in neural-crest derived structures of cranial ganglia of Dom mice; ( iii ) presence of a frameshift in the Sox10 coding region, and ( iv ) functional inactivation of the resulting truncated protein. These results identify the transcriptional regulator Sox10 as an essential factor in mouse neural crest development and as a further candidate gene for human Hirschsprung disease, especially in cases where it is associated with features of Waardenburg syndrome.

1 August 1993 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SLS. Lyonnet
S. Lyonnet
ABA. Bolino
A. Bolino
APA. Pelet
A. Pelet
LAL. Abel
L. Abel
CNC. Nihoul-Fékété
C. Nihoul-Fékété
GRG. Romeo
G. Romeo

1 November 2000 in BioTechniques
Verified
Journal Article
Open access
GPG. Patrone
G. Patrone
FPF. Puppo
F. Puppo
RCR. Cusano
R. Cusano
MSM. Scaranari
M. Scaranari
Isabella CeccheriniIsabella Ceccherini
Isabella Ceccherini
RRR. Ravazzolo
R. Ravazzolo
In this report, we present a fluorescencebased approach to the assessment of cellular gene expression and transcription rates. Nuclear run-on was performed by supplying biotin-16-UTP to nuclei, and...

1 December 2000 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
APAldamaria PULITI
Aldamaria PULITI
MSM Silengo
M Silengo
MLM Lerone
M Lerone
RRR Ravazzolo
R Ravazzolo

8 December 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
FMFrancesca Maltecca
Francesca Maltecca
EBElisa Baseggio
Elisa Baseggio
FCFrancesco Consolato
Francesco Consolato
DMDavide Mazza
Davide Mazza
PPPaola Podini
Paola Podini
GCGiorgio Casari
Giorgio Casari
Spinocerebellar ataxia type 28 (SCA28) is a neurodegenerative disease caused by mutations of the mitochondrial protease AFG3L2. The SCA28 mouse model, which is haploinsufficient for Afg3l2, exhibits a progressive decline in motor function and displays dark degeneration of Purkinje cells (PC-DCD) of mitochondrial origin. Here, we determined that mitochondria in cultured Afg3l2-deficient PCs ineffectively buffer evoked Ca2+ peaks, resulting in enhanced cytoplasmic Ca2+ concentrations, which subsequently triggers PC-DCD. This Ca2+-handling defect is the result of negative synergism between mitochondrial depolarization and altered organelle trafficking to PC dendrites in Afg3l2-mutant cells. In SCA28 mice, partial genetic silencing of the metabotropic glutamate receptor mGluR1 decreased Ca2+ influx in PCs and reversed the ataxic phenotype. Moreover, administration of the β-lactam antibiotic ceftriaxone, which promotes synaptic glutamate clearance, thereby reducing Ca2+ influx, improved ataxia-associated phenotypes in SCA28 mice when given either prior to or after symptom onset. Together, the results of this study indicate that ineffective mitochondrial Ca2+ handling in PCs underlies SCA28 pathogenesis and suggest that strategies that lower glutamate stimulation of PCs should be further explored as a potential treatment for SCA28 patients.